Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

Volume: 82, Issue: 1, Pages: 159 - 198
Published: Jan 1, 2021
Abstract
•No specific treatment against SARS-CoV-2 is available after 6 months of COVID-19 worldwide outbreak.•Antivirals could decrease the viral load and reduce direct and indirect damages of SARSCoV-2 infection.•Ritonavir-bosted lopinavir is effective against SARS-CoV-2 in vitro.•Sequential virological and pharmacological monitoring helped to understand the efficacy of ritonavir-boosted lopinavir in a SARS-CoV-2 infected patient.•Ritonavir-boosted...
Paper Details
Title
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
Published Date
Jan 1, 2021
Volume
82
Issue
1
Pages
159 - 198
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.